我国药品集中采购工作回顾与展望  

Review and Prospect of Drug's Centralized Purchasing System in China

作　　者：李琛 刘艺敏 王文杰 崔丹 张欲晓 殷潇 LI Chen;LIU Yi-min;WANG Wen-jie(College of Health Sciences,Wuhan University,Wuhan,Hubei,430071,China)

机构地区：[1]武汉大学健康学院,湖北武汉430071

出　　处：《中国医院管理》2018年第9期17-19,23,共4页Chinese Hospital Management

基　　金：国家自然科学基金资助项目(71573192);教育部人文社会科学项目(17YJC630220);中国科协"高端科技创新智库青年项目"(DXB-ZKQN-2017-040)

摘　　要：药品集中采购工作在我国已进行了20多年,迄今为止已经建立了以政府为主导、以省区市为单位的网上药品集中采购模式,此外各地还相继探索出独具特色的自主采购模式。通过文献研究等方法,对我国药品集中采购政策的发展历程以及现阶段典型的药品集中采购模式进行了梳理归纳,并就未来的药品集中采购工作进行了展望,为完善我国药品采购政策提供参考。The centralized procurement of medicines has been in China for more than 20 years,so far,a government-led,centralized drug procurement model has been established at provincial level. In addition,various regions have also explored their own unique procurement models. Through literature research,this paper induced and summarized the development process of the centralized drug procurement policy in China and the typical centralized drug procurement models,outlooked the future of centralized drug procurement,so as to provide reference for the improvement of drug purchasing policies in China.

关 键 词：药品集中采购 政策 演变 

分 类 号：R951[医药卫生—药学]